Track Senti Biosciences's receivables ($170K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Senti Biosciences (SNTI) currently reports a receivables of $170K as of March 2026. That compares with $130K in the prior-year period — up 35.4% year over year. Use the charts on this page to explore Senti Biosciences's receivables history and peer comparisons.
Senti Biosciences's receivables increased from $130K to $170K — a 35.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Senti Biosciences reported $170K in receivables as of March 2026. That compares with $130K in the prior-year period — up 35.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Senti Biosciences, and consider following SNTI for alerts when major investors trade the stock.